Understanding and managing hyperphosphatemia in patients with chronic renal diseaseMALLUCHE, H. H; MONIER-FAUGERE, M. C.Clinical nephrology. 1999, Vol 52, Num 5, pp 267-277, issn 0301-0430Article

Uremic bone disease : current knowledge, controversial issues, and new horizonsMALLUCHE, H. H; MONIER-FAUGERE, M.-C.Mineral and electrolyte metabolism. 1991, Vol 17, Num 4, pp 281-296, issn 0378-0392Article

Hyperphosphatemia : pharmacologic intervention yesterday, today and tomorrowMALLUCHE, H. H; MONIER-FAUGERE, M.-C.Clinical nephrology. 2000, Vol 54, Num 4, pp 309-317, issn 0301-0430Article

Renal Osteodystrophy in the First Decade of the New Millennium: Analysis of 630 Bone Biopsies in Black and White PatientsMALLUCHE, Hartmut H; MAWAD, Hanna W; MONIER-FAUGERE, Marie-Claude et al.Journal of bone and mineral research (Print). 2011, Vol 26, Num 6, pp 1368-1376, issn 0884-0431, 9 p.Article

Quality assurance-quality control in bone histopathology and bone histomorphometryMONIER-FAUGERE, M.-C.Bone (New York, NY). 1993, Vol 14, Num 3, pp 559-572, issn 8756-3282Conference Paper

A new bisphosphonate, BM 21.0955, prevents bone loss associated with cessation of ovarian function in experimental dogsMONIER-FAUGERE, M.-C; FRIEDLER, R. M; BAUSS, F et al.Journal of bone and mineral research (Print). 1993, Vol 8, Num 11, pp 1345-1355, issn 0884-0431Article

Differences in Bone Quality in Low- and High-Turnover Renal OsteodystrophyMALLUCHE, Hartmut H; PORTER, Daniel S; MONIER-FAUGERE, Marie-Claude et al.Journal of the American Society of Nephrology. 2012, Vol 23, Num 3, pp 525-532, issn 1046-6673, 8 p.Article

The importance of bone health in end-stage renal disease: out of the frying pan, into the fire?MALLUCHE, Hartmut H; MAWAD, Hanna; MONIER-FAUGERE, Marie-Claude et al.Nephrology, dialysis, transplantation (Print). 2004, Vol 19, pp i9-i13, issn 0931-0509, SUP1Conference Paper

Moderately high consumption of ethanol suppresses bone resorption in ovariectomized but not in sexually intact adult female ratsFANTI, P; MONIER-FAUGERE, M.-C; GENG, Z et al.Alcoholism, clinical and experimental research. 1997, Vol 21, Num 6, pp 1150-1154, issn 0145-6008Article

Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysisQUANLE QI; MONIER-FAUGERE, M.-C; ZHAOPO GENG et al.American journal of kidney diseases. 1995, Vol 26, Num 4, pp 622-631, issn 0272-6386Article

Short-term administration of the bisphosphonate ibandronate increases bone volume and prevents hyperparathyroid bone changes in mild experimental renal failureGENG, Z; MONIER-FAUGERE, M.-C; BAUSS, F et al.Clinical nephrology. 2000, Vol 54, Num 1, pp 45-53, issn 0301-0430Article

Calcitonin prevents bone loss but decreases osteoblastic activity in ovariohysterectomized beagle dogsMONIER-FAUGERE, M.-C; GENG, Z; QI, Q et al.Journal of bone and mineral research (Print). 1996, Vol 11, Num 4, pp 445-455, issn 0884-0431Article

High prevalence of low bone turnover and occurrence of osteomalacia after kidney transplantationMONIER-FAUGERE, M.-C; MAWAD, H; QUANLE QI et al.Journal of the American Society of Nephrology. 2000, Vol 11, Num 6, pp 1093-1099, issn 1046-6673Article

Trends in renal osteodystrophy : a survey from 1983 to 1995 in a total of 2248 patientsMONIER-FAUGERE, M.-C; MALLUCHE, H. H.Nephrology, dialysis, transplantation (Print). 1996, Vol 11, pp 111-120, issn 0931-0509, SUP3Conference Paper

Parathyroid hormone assays: evolution and revolutions in the care of dialysis patientsMALLUCHE, H. H; MAWAD, H; TRUEBA, D et al.Clinical nephrology. 2003, Vol 59, Num 5, pp 313-318, issn 0301-0430, 6 p.Article

CALCITONIN, SOMATOSTATIN AND ACTH IMMUNOREACTIVE CELLS IN A CASE OF FAMILIAL BILATERAL THYROID MEDULLARY CARCINOMACHARPIN C; ANDRAC L; MONIER FAUGERE MC et al.1982; CANCER; ISSN 0008-543X; USA; DA. 1982; VOL. 50; NO 9; PP. 1806-1814; BIBL. 40 REF.Article

SYNDROME DE COMPRESSION DU DEFILE COSTO-CLAVICULAIRE PAR TUMEUR DE LA PREMIERE COTEDEVIN R; BRANCHEREAU A; PELLISSIER JF et al.1981; CHIRURGIE; ISSN 0001-4001; FRA; DA. 1981; VOL. 107; NO 10; PP. 749-754; ABS. ENG; BIBL. 27 REF.Article

Use and indication of vitamin D and vitamin D analogues in patients with renal bone diseaseMALLUCHE, Hartmut H; MONIER-FAUGERE, Marie-Claude; KOSZEWSKI, Nick J et al.Nephrology, dialysis, transplantation (Print). 2002, Vol 17, pp 6-9, issn 0931-0509, SUP10Conference Paper

The phytoestrogen genistein reduces bone loss in short-term ovariectomized ratsFANTI, P; MONIER-FAUGERE, M. C; GENG, Z et al.Osteoporosis international. 1998, Vol 8, Num 3, pp 274-281, issn 0937-941XArticle

Systemic osteopenia and mineralization defect in patients with ankylosing spondylitisSZEJNFELD, V. L; MONIER-FAUGERE, M.-C; BOGNAR, B. J et al.Journal of rheumatology. 1997, Vol 24, Num 4, pp 683-688, issn 0315-162XConference Paper

Racial differences in parathyroid hormone levels in patients with secondary hyperparathyroidismSAWAYA, B. P; MONIER-FAUGERE, M.-C; RATANAPANICHKICH, P et al.Clinical nephrology. 2002, Vol 57, Num 1, pp 51-55, issn 0301-0430Article

Improved assessment of bone turnover by the PTH-(1-84)/large C-PTH fragments ratio in ESRD patientsMONIER-FAUGERE, Marie-Claude; ZHAOPO GENG; MAWAD, Hanna et al.Kidney international. 2001, Vol 60, Num 4, pp 1460-1468, issn 0085-2538Article

22-Oxacalcitriol suppresses secondary hyperparathyroidism without inducing low bone turnover in dogs with renal failureMONIER-FAUGERE, M.-C; ZHAOPO GENG; FRIEDLER, R. M et al.Kidney international. 1999, Vol 55, Num 3, pp 821-832, issn 0085-2538Conference Paper

Femoral bone mineral density reflects histologically determined cortical bone volume in hemodialysis patientsADRAGAO, T; HERBERTH, J; MONIER-FAUGERE, M.-C et al.Osteoporosis international. 2010, Vol 21, Num 4, pp 619-625, issn 0937-941X, 7 p.Article

Effect of bisphosphonates on vascular calcification and bone metabolism in experimental renal failureLOMASHVILI, Koba A; MONIER-FAUGERE, Marie-Claude; XIAONAN WANG et al.Kidney international. 2009, Vol 75, Num 6, pp 617-625, issn 0085-2538, 9 p.Article